Colivelin is primarily studied for its potential neuroprotective effects, particularly in the context of neurodegenerative diseases such as Alzheimer's disease. Research suggests it may help in preventing neuronal cell death by activating survival pathways in the brain. This has led to investigations into its use as a therapeutic agent to mitigate the progression of cognitive decline and memory loss associated with such conditions. Additionally, its role in promoting neuronal survival makes it a candidate for treating other neurological disorders where cell death is a significant factor. Studies are ongoing to explore its efficacy and safety in these applications.